Vertex Pharma (VRTX) Tops Q4 EPS by 6c
Tweet
Share
E-mail
Get Alerts VRTX Hot Sheet
Price: $508.34 -1.55%
Revenue Growth %: +10.7%
Financial Fact:
Provision for income taxes (Alios): 503K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +10.7%
Financial Fact:
Provision for income taxes (Alios): 503K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Vertex Pharma (NASDAQ: VRTX) reported Q4 EPS of $0.35, $0.06 better than the analyst estimate of $0.29. Revenue for the quarter came in at $458.71 versus the consensus estimate of $453.4 million.
For earnings history and earnings-related data on Vertex Pharma (VRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Investing.com’s stocks of the week
- Can global equities keep rising? UBS sees these factors driving upside
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
